TUSTIN, CA, January 18, 2007 – Integrium, a leading contract research organization (CRO) in the cardiovascular and metabolic areas, today announced key organizational changes. These changes reflect the company’s continued growth and commitment to delivering high-quality, efficient clinical trial services to its clients, as well as expanded operational capabilities.

TUSTIN, CA, October 11, 2006 – Integrium, a leading contract research organization (CRO) in the cardiovascular and metabolic areas, today announced that the company was awarded workscopes for two large hypertension studies by a major pharmaceutical company. This follows a number of trial workscopes previously managed by Integrium for this client.

TUSTIN, CA, September 7, 2006 – Integrium, a leading contract research organization (CRO) in the cardiovascular and metabolic areas, today announced the promotion of Richard Caroddo to Director of Business Development...